CARROLS RESTAURANT GROUP, INC.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000080924823000079 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q2

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.881M	$18.36M	$8.481M
YoY Change	-42.45%	-37.0%	-85.85%
Cash & Equivalents	$4.881M	$18.36M	$8.481M
Short-Term Investments
Other Short-Term Assets	$18.18M	$15.56M	$14.25M
YoY Change	27.62%	85.64%	-33.85%
Inventory	$12.94M	$14.42M	$13.17M
Prepaid Expenses
Receivables	$24.52M	$19.93M	$19.89M
Other Receivables	$0.00	$0.00	$147.0K
Total Short-Term Assets	$60.51M	$68.28M	$55.94M
YoY Change	8.17%	-0.11%	-48.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$305.2M	$312.3M	$335.3M
YoY Change	-8.97%	-7.51%	-8.18%
Goodwill	$107.8M	$107.8M	$124.5M
YoY Change	-13.42%	-13.42%	0.98%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.25M	$14.35M	$11.93M
YoY Change	2.65%	98.12%	57.11%
Total Long-Term Assets	$1.524B	$1.539B	$1.611B
YoY Change	-5.39%	-4.9%	-2.81%
TOTAL ASSETS
Total Short-Term Assets	$60.51M	$68.28M	$55.94M
Total Long-Term Assets	$1.524B	$1.539B	$1.611B
Total Assets	$1.584B	$1.608B	$1.666B
YoY Change	-4.94%	-4.7%	-5.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.53M	$30.49M	$30.38M
YoY Change	3.81%	-2.16%	-6.56%
Accrued Expenses	$96.98M	$115.9M	$100.6M
YoY Change	-3.64%	2.34%	11.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.368M	$7.341M	$6.289M
YoY Change	17.16%	26.7%	25.88%
Total Short-Term Liabilities	$173.5M	$179.4M	$166.5M
YoY Change	4.22%	6.39%	7.46%
LONG-TERM LIABILITIES
Long-Term Debt	$465.7M	$480.9M	$486.6M
YoY Change	-4.29%	3.36%	-4.36%
Other Long-Term Liabilities	$1.051M	$12.24M	$1.303M
YoY Change	-19.34%	911.82%	338.72%
Total Long-Term Liabilities	$466.8M	$12.24M	$487.9M
YoY Change	-4.33%	-97.38%	-4.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$173.5M	$179.4M	$166.5M
Total Long-Term Liabilities	$466.8M	$12.24M	$487.9M
Total Liabilities	$1.433B	$1.457B	$1.467B
YoY Change	-2.35%	-1.08%	-2.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$136.1M	-$137.0M	-$82.67M
YoY Change	64.65%	123.09%	135.55%
Common Stock	$294.3M	$293.2M	$290.3M
YoY Change	1.4%	1.7%	-6.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.43M	$14.13M	$14.13M
YoY Change	2.11%	0.02%	0.0%
Treasury Stock Shares
Shareholders Equity	$151.4M	$150.8M	$199.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.584B	$1.608B	$1.666B
YoY Change	-4.94%	-4.7%	-5.66%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000809248
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-02
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	001-33174
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	CARROLS RESTAURANT GROUP, INC.
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3804854
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	968 James Street
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Syracuse,
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	13203
CY2023Q2	dei	City Area Code CityAreaCode	315
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	424-0513
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, par value $.01 per share
CY2023Q2	dei	Trading Symbol TradingSymbol	TAST
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54065151	shares
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4881000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18364000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	24515000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	19933000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	12938000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14417000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18179000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15562000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	60513000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	68276000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	546308000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	535359000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	305224000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	312346000	usd
CY2023Q2	tast	Franchise Rights Accumulated Amortization FranchiseRightsAccumulatedAmortization	164295000	usd
CY2023Q1	tast	Franchise Rights Accumulated Amortization FranchiseRightsAccumulatedAmortization	161426000	usd
CY2023Q2	tast	Finite Lived Franchise Rights Net FiniteLivedFranchiseRightsNet	309075000	usd
CY2023Q1	tast	Finite Lived Franchise Rights Net FiniteLivedFranchiseRightsNet	312804000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	107751000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	107751000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17670000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16975000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27619000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28256000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	761754000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	763935000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12245000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14350000	usd
CY2023Q2	us-gaap	Assets Assets	1584181000	usd
CY2023Q1	us-gaap	Assets Assets	1607718000	usd
CY2023Q2	tast	Long Term Debt Currentand Finance Lease Liabilities LongTermDebtCurrentandFinanceLeaseLiabilities	7368000	usd
CY2023Q1	tast	Long Term Debt Currentand Finance Lease Liabilities LongTermDebtCurrentandFinanceLeaseLiabilities	7341000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	47948000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	47408000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	31533000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	30491000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	5074000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	9643000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37173000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49934000	usd
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	6782000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	8896000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37639000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25687000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	173517000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	179400000	usd
CY2023Q2	tast	Long Term Debt Noncurrentand Finance Lease Liabilities LongTermDebtNoncurrentandFinanceLeaseLiabilities	465735000	usd
CY2023Q1	tast	Long Term Debt Noncurrentand Finance Lease Liabilities LongTermDebtNoncurrentandFinanceLeaseLiabilities	479756000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	774927000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	776465000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8546000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7665000	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	10085000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	13590000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1432810000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1456876000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56316888	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54928225	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51526036	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50903111	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	538000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	530000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	293797000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	292708000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136104000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136968000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7565000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8702000	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	14425000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	14130000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	151371000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	150842000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1584181000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1607718000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445162000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	399476000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	125443000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123057000	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	146324000	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141620000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	31834000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	31013000	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	69132000	usd
CY2022Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	65407000	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	17898000	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	15964000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1097000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1941000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25740000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22017000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18718000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19542000	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1340000	usd
CY2022Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	496000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1506000	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-202000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	434923000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	419318000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	10239000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-19842000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	8233000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	7436000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2006000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27278000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1142000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6009000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50460279	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61420034	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50460279	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1137000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4282000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-273000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16987000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	150842000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1097000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2023Q2	tast	Repurchaseof Treasury Stock RepurchaseofTreasuryStock	295000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	260000	usd
CY2023Q2	tast	Changein Valuationof Interest Rate Swap ChangeinValuationofInterestRateSwap	1137000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	151371000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	214224000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1941000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2022Q2	tast	Repurchaseof Treasury Stock RepurchaseofTreasuryStock	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1268000	usd
CY2022Q2	tast	Changein Valuationof Interest Rate Swap ChangeinValuationofInterestRateSwap	-4282000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	199178000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1521000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-218000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1097000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1941000	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1340000	usd
CY2022Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	496000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18718000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19542000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	543000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	543000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	32000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	32000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1142000	usd
CY2022Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	6009000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14222000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	22063000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7993000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26569000	usd
CY2023Q2	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	858000	usd
CY2022Q2	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	2622000	usd
CY2023Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2035000	usd
CY2022Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	5319000	usd
CY2023Q2	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	3774000	usd
CY2022Q2	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	4151000	usd
CY2023Q2	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1322000	usd
CY2022Q2	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1097000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7989000	usd
CY2022Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	13189000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	0	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	635000	usd
CY2023Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1126000	usd
CY2022Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6863000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12554000	usd
CY2023Q2	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1063000	usd
CY2022Q2	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1063000	usd
CY2023Q2	tast	Borrowings Under Prior Revolving Credit Facility BorrowingsUnderPriorRevolvingCreditFacility	11000000	usd
CY2022Q2	tast	Borrowings Under Prior Revolving Credit Facility BorrowingsUnderPriorRevolvingCreditFacility	47750000	usd
CY2023Q2	tast	Repayments Under Prior Revolving Credit Facility RepaymentsUnderPriorRevolvingCreditFacility	23500000	usd
CY2022Q2	tast	Repayments Under Prior Revolving Credit Facility RepaymentsUnderPriorRevolvingCreditFacility	27750000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	755000	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	484000	usd
CY2023Q2	tast	Purchase From Sale Of Treasury Stock PurchaseFromSaleOfTreasuryStock	295000	usd
CY2022Q2	tast	Purchase From Sale Of Treasury Stock PurchaseFromSaleOfTreasuryStock	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14613000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18453000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13483000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20670000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18364000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29151000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4881000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8481000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	12137000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	11260000	usd
CY2023Q2	tast	Interest Paid On Lease Financing Obligations InterestPaidOnLeaseFinancingObligations	0	usd
CY2022Q2	tast	Interest Paid On Lease Financing Obligations InterestPaidOnLeaseFinancingObligations	26000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	208000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	108000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1945000	usd
CY2022Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2920000	usd
CY2023Q2	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	20000	usd
CY2022Q2	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3038000	usd
CY2023Q2	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	822000	usd
CY2022Q2	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	-74000	usd
CY2023Q2	tast	Accrual For Financing Costs AccrualForFinancingCosts	10819000	usd
CY2022Q2	tast	Accrual For Financing Costs AccrualForFinancingCosts	5620000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	25739000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	25521000	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	10085000	usd
CY2023Q2	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Company uses a 52-53 week fiscal year ending on the Sunday closest to December 31. The three months ended April 2, 2023 and April 3, 2022 each contained thirteen weeks. The 2023 fiscal year will end December 31, 2023 and will contain 52 weeks.</span>
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The preparation of the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates include accrued occupancy costs, insurance liabilities, lease accounting matters, the valuation of acquired assets and liabilities, interest rate swap valuation, the valuation of deferred income tax assets and liabilities, and the evaluation for impairment of goodwill, long-lived assets and franchise rights. Actual results could differ from those estimates.</span>
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	13590000	usd
CY2023Q2	tast	Accrued Interest Rate Swap Noncurrent Fair Value AccruedInterestRateSwapNoncurrentFairValue	7200000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	100000	usd
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	200000	usd
CY2023Q2	tast	Franchise Agreement Number Of Renewal Periods FranchiseAgreementNumberOfRenewalPeriods	1	period
CY2023Q2	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2023Q2	tast	Amortizationofintangibleassetsfranchiserights Amortizationofintangibleassetsfranchiserights	3500000	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1300000	usd
CY2022Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	500000	usd
CY2022Q2	tast	Asset Impairment Charges Numberof Restaurants AssetImpairmentChargesNumberofRestaurants	1	restaurant
CY2022Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	300000	usd
CY2023Q2	tast	Accrual For Occupancy Costs Noncurrent AccrualForOccupancyCostsNoncurrent	1701000	usd
CY2023Q1	tast	Accrual For Occupancy Costs Noncurrent AccrualForOccupancyCostsNoncurrent	1797000	usd
CY2023Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	3388000	usd
CY2023Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	5239000	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2612000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3002000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1333000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1347000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1051000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2205000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P20Y
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5471000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	4409000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	825000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	487000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	208000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	108000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	33172000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	31821000	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	12090000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	12826000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	478653000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	492951000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7368000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7341000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5129000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5401000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	421000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	453000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	465735000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	479756000	usd
CY2019Q4	tast	First Lien Leverage Ratio FirstLienLeverageRatio	5.75
CY2019Q4	tast	Letters Of Credit Undrawn Maximum LettersOfCreditUndrawnMaximum	12000000	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10500000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	204500000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.058
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.049
CY2021Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40
CY2023Q2	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	220000000	usd
CY2021Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	120000000	usd
CY2023Q2	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	1100000	usd
CY2022Q2	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	200000	usd
CY2022Q2	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	200000	usd
CY2023Q2	tast	Accrued Interest Rate Swap Noncurrent Fair Value AccruedInterestRateSwapNoncurrentFairValue	7200000	usd
CY2023Q2	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	4700000	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2473000	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8216000	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1331000	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2207000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1142000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6009000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.187	rate
CY2023Q2	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	800000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2022Q2	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	0	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	124400000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	43900000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43000000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	44300000	usd
CY2023Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1300000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1100000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1900000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5700000	usd
CY2023Q2	tast	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Value Expected To Vest In Remainder Of Fiscal Year EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedValueExpectedToVestInRemainderOfFiscalYear	2600000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1767811	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.79
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1386722	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.04
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	753818	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.28
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	11600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.48
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2389115	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.62
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.12
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	975500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.12
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	975500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.12
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	975500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	7.12
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	868250	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.12
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q2	us-gaap	Share Price SharePrice	2.23
CY2023Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	10300000	usd
CY2023Q2	tast	Guarantor Obligations Payments Made GuarantorObligationsPaymentsMade	0	usd
CY2023Q2	tast	Guarantor Obligations Expected Future Payments GuarantorObligationsExpectedFuturePayments	0	usd
CY2023Q2	tast	Number Of Distributors NumberOfDistributors	5	distributor
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2023Q2	tast	Convertible Preferred Stock Common Shares Issuable Upon Conversion ConvertiblePreferredStockCommonSharesIssuableUponConversion	9414580	shares
CY2023Q2	tast	Board Of Directors Number Of Members BoardOfDirectorsNumberOfMembers	2
CY2023Q2	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2023Q2	tast	Franchise Term FranchiseTerm	20	y
CY2023Q2	tast	Monthly Digital Platform Fee MonthlyDigitalPlatformFee	700000	usd
CY2021Q1	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	50	restaurant
CY2021Q1	tast	Area Development Agreement Percentage Of New Restaurants To Be In Kentucky Tennessee And Indiana AreaDevelopmentAgreementPercentageOfNewRestaurantsToBeInKentuckyTennesseeAndIndiana	0.80
CY2021Q3	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	4	restaurant
CY2022Q3	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	10	restaurant
CY2023Q1	tast	Area Development Agreement Restaurants Completed AreaDevelopmentAgreementRestaurantsCompleted	6	restaurant
CY2021Q1	tast	Area Development Agreement Number Of Restaurants To Be Acquired AreaDevelopmentAgreementNumberOfRestaurantsToBeAcquired	500	restaurant
CY2021Q1	tast	Area Development Agreement Number Of States AreaDevelopmentAgreementNumberOfStates	16	state
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	704000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21269000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50460279	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21269000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50460279	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9998024	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61420034	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50460279	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11920450	shares
CY2023Q2	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	900000	usd
CY2023Q2	us-gaap	Sales Type And Direct Financing Leases Profit Loss SalesTypeAndDirectFinancingLeasesProfitLoss	800000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	200000	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	300000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Profit Loss SalesTypeAndDirectFinancingLeasesProfitLoss	100000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000809248-23-000079-index-headers.html	Edgar Link	pending
0000809248-23-000079-index.html	Edgar Link	pending
0000809248-23-000079.txt	Edgar Link	pending
0000809248-23-000079-xbrl.zip	Edgar Link	pending
debderbyemploymentagreement.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
insidertradingagreement.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tast-20230402.htm	Edgar Link	pending
tast-20230402.xsd	Edgar Link	pending
tast-ex311_20230402.htm	Edgar Link	pending
tast-ex312_20230402.htm	Edgar Link	pending
tast-ex321_20230402.htm	Edgar Link	pending
tast-ex322_20230402.htm	Edgar Link	pending
tast-20230402_cal.xml	Edgar Link	unprocessable
tast-20230402_def.xml	Edgar Link	unprocessable
tast-20230402_pre.xml	Edgar Link	unprocessable
tast-20230402_lab.xml	Edgar Link	unprocessable
tast-20230402_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

CARROLS RESTAURANT GROUP, INC.

2023 Q2 Form 10-Q Financial Statement

#000080924823000079 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission